Alimera Sciences Inc
ALIMDelisted Sep 16, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001267602
Alimera Sciences Inc was delisted on Sep 16, 2024; its insiders filed their last Form 4 on Sep 18, 2024; 52 institutions reported holding it in 13F filings for Q2 2024, worth $257.9M in total; no superinvestor held it.
13F holders, Q1 2024
Institutional positions in Alimera Sciences Inc as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 39
- +4 vs. Q4 2023
- Shares held
- 47.9M
- −327.0K (−0.7%) vs. Q4 2023
- Total value
- $186.9M
- −$21.5M (−10.3%) vs. Q4 2023
- New holders
- 10
- 16 more added
- Sold out
- 6
- 6 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ALIM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 52 | $257.9M |
| Q1 2024 | 39 | $186.9M |
| Q4 2023 | 35 | $208.4M |
| Q3 2023 | 30 | $146.5M |
| Q2 2023 | 18 | $10.3M |
| Q1 2023 | 16 | $4.30M |
| Q4 2022 | 20 | $6.13M |
| Q3 2022 | 14 | $8.73M |
| Q2 2022 | 20 | $9.00M |
| Q1 2022 | 18 | $8.49M |
| Q4 2021 | 21 | $9.09M |
| Q3 2021 | 27 | $8.29M |
| Q2 2021 | 25 | $17.9M |
| Q1 2021 | 25 | $18.1M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Alimera Sciences Inc; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 22 | $0 | 0.00% | 00.0% | Unchanged |
| Macquarie Group Ltd | 523 | $2 | 0.00% | +523 | New |
| Comerica Bank | 14 | $55 | 0.00% | 00.0% | Unchanged |
| Syntax Research, Inc. | 80 | $312 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 287 | $1.12K | 0.00% | +5+1.8% | Added |
| Steward Partners Investment Advisory, LLC | 666 | $2.60K | 0.00% | +666 | New |
| Tower Research Capital LLC (TRC) | 944 | $3.68K | 0.00% | +644+214.7% | Added |
| Advisor Group Holdings, Inc. | 4,065 | $15.9K | 0.00% | 00.0% | Unchanged |
| Balyasny Asset Management LLC | 10,323 | $40.3K | 0.00% | −29,709−74.2% | Reduced |
| Fifth Lane Capital, LP | 21,238 | $82.8K | 0.11% | +21,238 | New |
| JPMorgan Chase & Co | 22,135 | $86.3K | 0.00% | +22,074+36,186.9% | Added |
| Bank of America Corp | 23,524 | $91.7K | 0.00% | +2,728+13.1% | Added |
| HRT Financial LP | 25,586 | $99.0K | 0.00% | +25,586 | New |
| Jefferies Financial Group Inc. | 26,100 | $101.8K | 0.00% | +13,200+102.3% | Added |
| Citadel Advisors LLC | 28,871 | $112.6K | 0.00% | +8,997+45.3% | Added |
| Hillsdale Investment Management Inc. | 43,400 | $169.3K | 0.01% | +43,400 | New |
| Qube Research & Technologies Ltd | 46,678 | $182.0K | 0.00% | +46,678 | New |
| Citigroup Inc | 61,420 | $239.5K | 0.00% | +30,612+99.4% | Added |
| Goldman Sachs Group Inc | 71,758 | $279.9K | 0.00% | +71,758 | New |
| Northern Trust Corp | 73,418 | $286.3K | 0.00% | +59,286+419.5% | Added |
| Marshall Wace, LLP | 85,301 | $332.7K | 0.00% | +85,301 | New |
| Susquehanna International Group, LLP | 107,101 | $417.7K | 0.00% | −3,509−3.2% | Reduced |
| Millennium Management LLC | 126,159 | $492.0K | 0.00% | +93,698+288.6% | Added |
| State Street Corp | 133,016 | $518.8K | 0.00% | +133,016 | New |
| Bridgeway Capital Management, LLC | 139,100 | $542.5K | 0.01% | +119,100+595.5% | Added |
| Renaissance Technologies LLC | 174,794 | $682.0K | 0.00% | +16,000+10.1% | Added |
| Bank of Montreal | 188,067 | $757.9K | 0.00% | +63,770+51.3% | Added |
| Ancora Advisors, LLC | 234,620 | $915.0K | 0.02% | +234,620 | New |
| Geode Capital Management, LLC | 378,237 | $1.48M | 0.00% | +46,260+13.9% | Added |
| BlackRock Inc. | 483,294 | $1.88M | 0.00% | +39,455+8.9% | Added |
| Morgan Stanley | 501,738 | $1.96M | 0.00% | −414,508−45.2% | Reduced |
| Vanguard Group Inc | 1,045,460 | $4.08M | 0.00% | +396,506+61.1% | Added |
| AIGH Capital Management LLC | 1,520,359 | $5.93M | 2.86% | −705,709−31.7% | Reduced |
| Clearline Capital LP | 2,085,291 | $8.13M | 0.80% | −83,852−3.9% | Reduced |
| Altium Capital Management LP | 2,550,000 | $9.95M | 4.44% | −110,000−4.1% | Reduced |
| Boothbay Fund Management, LLC | 3,198,708 | $12.5M | 0.37% | 00.0% | Unchanged |
| Stonepine Capital Management, LLC | 4,051,072 | $15.8M | 12.53% | +51,613+1.3% | Added |
| Velan Capital Investment Management LP | 13,608,533 | $53.1M | 28.70% | 00.0% | Unchanged |
| Caligan Partners LP | 16,835,154 | $65.7M | 17.36% | 00.0% | Unchanged |
| Worth Venture Partners, LLC | 0 | $0 | 0.00% | −556,642−100.0% | Sold out |
| HighTower Advisors, LLC | 0 | $0 | 0.00% | −25,091−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −19,376−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −5,263−100.0% | Sold out |
| Focused Wealth Management, Inc | 0 | $0 | 0.00% | −66−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −2−100.0% | Sold out |